Thousands of men claim finasteride, a drug that many start taking in their 20s and 30s to avoid hair loss, has left them with ...

Long-term anxiety can be ameliorated through better self-regulation, including hypnosis and taking positive actions.

Groundbreaking research reveals that it's possible to isolate the therapeutic benefits of psychedelics from their ...

New research suggests that it could be possible to separate treatment from hallucinations when developing new drugs based on psychedelics.

The recent volatility in key GLP-1 stocks has put the spotlight on the anxiety Wall Street has about the weight loss market.

Hims & Hers offers personalized telehealth services, with a stock price that reflects high-growth potential. See why we ...

Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon One ...

Hims & Hers Health's stock dropped 25% due to Amazon’s competition. Learn why HIM stock's 38% upside and strong growth make ...

If you’re dealing with male pattern baldness, there’s a good chance you’ve heard of or use finasteride. You also may have ...

Hims & Hers (HIMS) stock price remained on edge even after the fast-growing telehealth company published strong financial ...

Hims & Hers currently offers compounded GLP-1 weight-loss injections at $199 per month and weight management oral medication kits at $79 per month. Soaring demand for weight-loss drugs such as Wegovy ...

Direct-to-consumer telehealth company Hims & Hers is defending its sale of compounded glucagon-like peptide agonists, or GLP-1s, even as shortages of the name brand weight loss medications are waning.